GEMMA Biotherapeutics, co-founded by James Wilson, MD, PhD, the Rose H. Weiss Orphan Disease Center Director’s Professor at Penn Medicine, announced the launch of Rare Therapeutics, a clinical-stage company focused on developing accessible and sustainable gene therapies for ultra-orphan diseases. Read more here.